Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 478

1.

Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.

Rice SR, Vyfhuis MAL, Scilla KA, Burrows WM, Bhooshan N, Suntharalingam M, Edelman MJ, Feliciano J, Badiyan SN, Simone CB 2nd, Bentzen SM, Feigenberg SJ, Mohindra P.

Clin Lung Cancer. 2019 Sep 18. pii: S1525-7304(19)30258-X. doi: 10.1016/j.cllc.2019.08.009. [Epub ahead of print]

PMID:
31708388
2.

Patients' Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial.

Edelman M, Jellema P, Hak E, Denig P, Blanker MH.

Drugs Aging. 2019 Dec;36(12):1133-1139. doi: 10.1007/s40266-019-00712-6.

3.
4.
5.

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.

Arora S, Velichinskii R, Lesh RW, Ali U, Kubiak M, Bansal P, Borghaei H, Edelman MJ, Boumber Y.

Adv Ther. 2019 Oct;36(10):2638-2678. doi: 10.1007/s12325-019-01051-z. Epub 2019 Aug 13. Review.

6.

Congenital Hepatoblastoma and Beckwith-Wiedemann Syndrome.

Zivot A, Edelman M, Glick R, Hong A, Fish JD.

J Pediatr Hematol Oncol. 2019 Jul 19. doi: 10.1097/MPH.0000000000001565. [Epub ahead of print]

PMID:
31335825
7.

SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).

Edelman MJ, Redman MW, Albain KS, McGary EC, Rafique NM, Petro D, Waqar SN, Minichiello K, Miao J, Papadimitrakopoulou VA, Kelly K, Gandara DR, Herbst RS.

J Thorac Oncol. 2019 Oct;14(10):1853-1859. doi: 10.1016/j.jtho.2019.06.027. Epub 2019 Jul 11.

PMID:
31302234
8.

The use of 3D printing in shared decision making for a juvenile aggressive ossifying fibroma in a pediatric patient.

Lee AY, Patel NA, Kurtz K, Edelman M, Koral K, Kamdar D, Goldstein T.

Am J Otolaryngol. 2019 Sep - Oct;40(5):779-782. doi: 10.1016/j.amjoto.2019.07.001. Epub 2019 Jul 2.

PMID:
31285063
9.

Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patients.

Steffen LE, Cheavens JS, Vowles KE, Gabbard J, Nguyen H, Gan GN, Edelman MJ, Smith BW.

Support Care Cancer. 2020 Feb;28(2):827-835. doi: 10.1007/s00520-019-04878-y. Epub 2019 Jun 1.

PMID:
31152302
10.

An immigrant teen from Bangladesh with fever, abdominal pain, and ascites: A diagnostic challenge.

Eid D, Prince JM, Edelman MC, Hagmann SHF.

Travel Med Infect Dis. 2019 Feb 28:101380. doi: 10.1016/j.tmaid.2019.01.015. [Epub ahead of print] No abstract available.

PMID:
30825523
11.

USP6 Gene Rearrangement by FISH Analysis in Cranial Fasciitis: A Report of Three Cases.

Salib C, Edelman M, Lilly J, Fantasia JE, Yancoskie AE.

Head Neck Pathol. 2019 Feb 13. doi: 10.1007/s12105-019-01018-0. [Epub ahead of print]

PMID:
30758758
12.

Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.

Hamy AS, Tury S, Wang X, Gao J, Pierga JY, Giacchetti S, Brain E, Pistilli B, Marty M, Espié M, Benchimol G, Laas E, Laé M, Asselain B, Aouchiche B, Edelman M, Reyal F.

J Clin Oncol. 2019 Mar 10;37(8):624-635. doi: 10.1200/JCO.18.00636. Epub 2019 Jan 31.

13.

The Impact of Pathological Criteria on Pediatric Negative Appendectomy Rate.

Maloney C, Edelman MC, Bolognese AC, Lipskar AM, Rich BS.

J Pediatr Surg. 2019 Sep;54(9):1794-1799. doi: 10.1016/j.jpedsurg.2018.10.106. Epub 2018 Dec 28.

PMID:
30685199
14.

Epiphyseal Primary Diffuse Large B-Cell Lymphoma of Bone.

Kenan S, Kahn L, Edelman M, Redner A, Kenan S.

Case Rep Pathol. 2018 Nov 26;2018:4160925. doi: 10.1155/2018/4160925. eCollection 2018.

15.

Differential Gene Expression in Erlotinib-Treated Fibroblasts.

Wickersham KE, Hodges TK, Edelman MJ, Song Y, Nan M, Dorsey SG.

Nurs Res. 2019 Mar/Apr;68(2):110-126. doi: 10.1097/NNR.0000000000000330.

PMID:
30540703
16.

A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.

Stinchcombe TE, Fan W, Schild SE, Vokes EE, Bogart J, Le QT, Thomas CR, Edelman MJ, Horn L, Komaki R, Cohen HJ, Kishor Ganti A, Pang H, Wang X.

Cancer. 2019 Feb 1;125(3):382-390. doi: 10.1002/cncr.31813. Epub 2018 Oct 21.

PMID:
30343497
17.

Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.

Rice SR, Molitoris JK, Vyfhuis MAL, Edelman MJ, Burrows WM, Feliciano J, Nichols EM, Suntharalingam M, Donahue J, Carr SR, Friedberg J, Badiyan S, Simone CB 2nd, Feigenberg SJ, Mohindra P.

Clin Lung Cancer. 2019 Jan;20(1):e107-e114. doi: 10.1016/j.cllc.2018.09.014. Epub 2018 Sep 24.

PMID:
30337268
18.

Photosystem-II D1 protein mutants of Chlamydomonas reinhardtii in relation to metabolic rewiring and remodelling of H-bond network at QB site.

Antonacci A, Lambreva MD, Margonelli A, Sobolev AP, Pastorelli S, Bertalan I, Johanningmeier U, Sobolev V, Samish I, Edelman M, Havurinne V, Tyystjärvi E, Giardi MT, Mattoo AK, Rea G.

Sci Rep. 2018 Oct 3;8(1):14745. doi: 10.1038/s41598-018-33146-y.

19.

Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection.

Scilla KA, Zandberg DP, Bentzen SM, Mainor C, Heath J, Ioffe OB, Cellini AL, Edelman MJ, Riedel DJ, Feliciano JL.

Lung Cancer. 2018 Sep;123:87-90. doi: 10.1016/j.lungcan.2018.06.028. Epub 2018 Jun 26.

PMID:
30089601
20.

Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.

Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H.

JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251.

21.

Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622).

Feliciano JL, Le-Rademacher JG, Gajra A, Edelman MJ, Zemla T, McMurray R, Chen H, Hurria A, Muss H, Cohen HJ, Lilenbaum R, Jatoi A.

J Geriatr Oncol. 2018 Sep;9(5):501-506. doi: 10.1016/j.jgo.2018.05.006. Epub 2018 May 27.

22.

Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).

Gajra A, Zemla TJ, Jatoi A, Feliciano JL, Wong ML, Chen H, Maggiore R, McMurray RP, Hurria A, Muss HB, Cohen HJ, Lafky J, Edelman MJ, Lilenbaum R, Le-Rademacher JG.

J Thorac Oncol. 2018 Jul;13(7):996-1003. doi: 10.1016/j.jtho.2018.03.020. Epub 2018 Mar 30.

23.

Intratibial Injection Causes Direct Pulmonary Seeding of Osteosarcoma Cells and Is Not a Spontaneous Model of Metastasis: A Mouse Osteosarcoma Model.

Maloney C, Edelman MC, Kallis MP, Soffer SZ, Symons M, Steinberg BM.

Clin Orthop Relat Res. 2018 Jul;476(7):1514-1522. doi: 10.1007/s11999.0000000000000291.

24.

Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer.

Vyfhuis MAL, Burrows WM, Bhooshan N, Suntharalingam M, Donahue JM, Feliciano J, Badiyan S, Nichols EM, Edelman MJ, Carr SR, Friedberg J, Henry G, Stewart S, Sachdeva A, Pickering EM, Simone CB 2nd, Feigenberg SJ, Mohindra P.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):445-452. doi: 10.1016/j.ijrobp.2018.02.003. Epub 2018 Feb 13.

PMID:
29559292
25.

On stability of fixed points and chaos in fractional systems.

Edelman M.

Chaos. 2018 Feb;28(2):023112. doi: 10.1063/1.5016437.

PMID:
29495677
26.

Corrigendum to "Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer" [Lung Cancer 114, (December 2017) 44-49].

Vyfhuis MAL, Bhooshan N, Molitoris J, Bentzen SM, Feliciano J, Edelman M, Burrows WM, Nichols EM, Suntharalingam M, Donahue J, Nagib M, Carr SR, Friedberg J, Badiyan S, Simone CB 2nd, Feigenberg SJ, Mohindra P.

Lung Cancer. 2018 Feb;116:105. doi: 10.1016/j.lungcan.2017.12.011. Epub 2017 Dec 27. No abstract available.

PMID:
29289353
27.

Perinatal hemorrhage from ulceration of the umbilical cord: A potentially catastrophic association with duodenal and jejunal obstruction.

Aronowitz D, Dolgin S, Bornstein E, Little-Richardson A, Bajaj J, Williamson A, Naves-Ruiz E, Edelman M.

J Pediatr Surg. 2018 Sep;53(9):1669-1674. doi: 10.1016/j.jpedsurg.2017.11.045. Epub 2017 Nov 21.

PMID:
29241965
28.

Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer.

Vyfhuis MAL, Bhooshan N, Molitoris J, Bentzen SM, Feliciano J, Edelman M, Burrows WM, Nichols EM, Suntharalingam M, Donahue J, Nagib M, Carr SR, Friedberg J, Badiyan S, Simone CB 2nd, Feigenberg SJ, Mohindra P.

Lung Cancer. 2017 Dec;114:44-49. doi: 10.1016/j.lungcan.2017.10.016. Epub 2017 Nov 2. Erratum in: Lung Cancer. 2017 Dec 27;:.

PMID:
29173764
29.

Daily diary study of hope, stigma, and functioning in lung cancer patients.

Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ.

Health Psychol. 2018 Mar;37(3):218-227. doi: 10.1037/hea0000570. Epub 2017 Nov 27.

30.

Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.

Vyfhuis MAL, Bhooshan N, Burrows WM, Turner M, Suntharalingam M, Donahue J, Nichols EM, Feliciano J, Bentzen SM, Badiyan S, Carr SR, Friedberg J, Simone CB 2nd, Edelman MJ, Feigenberg SJ, Mohindra P.

Adv Radiat Oncol. 2017 Jul 31;2(3):259-269. doi: 10.1016/j.adro.2017.07.009. eCollection 2017 Jul-Sep.

31.

Solid pseudopapillary neoplasm presenting as a primary ovarian mass in an eighteen-year-old female: report of a case and review of the literature.

Komforti MK, Edelman M, Fan C, Liang SX.

Virchows Arch. 2018 Feb;472(2):285-291. doi: 10.1007/s00428-017-2231-y. Epub 2017 Sep 9. Review. No abstract available.

PMID:
28889196
32.

Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.

Adams DL, Adams DK, He J, Kalhor N, Zhang M, Xu T, Gao H, Reuben JM, Qiao Y, Komaki R, Liao Z, Edelman MJ, Tang CM, Lin SH.

Clin Cancer Res. 2017 Oct 1;23(19):5948-5958. doi: 10.1158/1078-0432.CCR-17-0802. Epub 2017 Jul 5.

33.

Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839.

Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD.

J Thorac Oncol. 2017 Sep;12(9):1413-1420. doi: 10.1016/j.jtho.2017.06.007. Epub 2017 Jun 16.

34.

Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.

Scilla KA, Bentzen SM, Lam VK, Mohindra P, Nichols EM, Vyfhuis MA, Bhooshan N, Feigenberg SJ, Edelman MJ, Feliciano JL.

Oncologist. 2017 Jun;22(6):737-742. doi: 10.1634/theoncologist.2016-0443. Epub 2017 May 22.

35.

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE; Alliance for Clinical Trials in Oncology.

J Clin Oncol. 2017 Jul 1;35(19):2184-2192. doi: 10.1200/JCO.2016.71.3743. Epub 2017 May 10.

36.

Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).

Lam VK, Bentzen SM, Mohindra P, Nichols EM, Bhooshan N, Vyfhuis M, Scilla KA, Feigenberg SJ, Edelman MJ, Feliciano JL.

Lung Cancer. 2017 Feb;104:52-57. doi: 10.1016/j.lungcan.2016.11.017. Epub 2016 Dec 1.

PMID:
28213000
37.

Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial.

Lesaffre E, Edelman MJ, Hanna NH, Park K, Thatcher N, Willemsen S, Gaschler-Markefski B, Kaiser R, Manegold C.

Ann Oncol. 2017 Jul 1;28(7):1419-1426. doi: 10.1093/annonc/mdx042.

PMID:
28184431
38.

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).

Baggstrom MQ, Socinski MA, Wang XF, Gu L, Stinchcombe TE, Edelman MJ, Baker S Jr, Feliciano J, Novotny P, Hahn O, Crawford JA, Vokes EE.

J Thorac Oncol. 2017 May;12(5):843-849. doi: 10.1016/j.jtho.2017.01.022. Epub 2017 Feb 1.

39.

A case of bronchial granular cell tumor in a pediatric patient.

Esterson YB, Edelman MC, Lipskar AM, Glassman LR, Assaad P.

Clin Imaging. 2017 May - Jun;43:15-18. doi: 10.1016/j.clinimag.2017.01.008. Epub 2017 Jan 25.

PMID:
28160713
40.

Whole-Brain Radiation in the Treatment of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.

Molitoris JK, Edelman MJ, Regine WF, Feigenberg SJ.

J Clin Oncol. 2017 Mar;35(7):809-810. doi: 10.1200/JCO.2016.69.7227. Epub 2016 Dec 28. No abstract available.

PMID:
28029324
41.

Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung.

Spigel DR, Edelman MJ, O'Byrne K, Paz-Ares L, Mocci S, Phan S, Shames DS, Smith D, Yu W, Paton VE, Mok T.

J Clin Oncol. 2017 Feb;35(4):412-420. doi: 10.1200/JCO.2016.69.2160. Epub 2016 Dec 12.

PMID:
27937096
42.

Highlights in the Treatment of Lung Cancer: What's New? Not Much.

Edelman MJ.

JAMA Oncol. 2017 Mar 1;3(3):301-302. doi: 10.1001/jamaoncol.2016.3984. No abstract available.

PMID:
27812684
43.

Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC.

Bhooshan N, Staats PN, Fulton AM, Feliciano JL, Edelman MJ.

Lung Cancer. 2016 Nov;101:88-91. doi: 10.1016/j.lungcan.2016.09.011. Epub 2016 Sep 14.

PMID:
27794413
44.

Erratum to: Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.

Edelman MJ, Lapidus R, Feliciano J, Styblo M, Beumer JH, Liu T, Gobburu J.

Cancer Chemother Pharmacol. 2016 Nov;78(5):969. No abstract available.

PMID:
27677624
45.

Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.

Edelman MJ, Lapidus R, Feliciano J, Styblo M, Beumer JH, Liu T, Gobbru J.

Cancer Chemother Pharmacol. 2016 Nov;78(5):959-967. Epub 2016 Sep 12. Erratum in: Cancer Chemother Pharmacol. 2016 Nov;78(5):969.

PMID:
27620207
46.

Nutrient Value of Leaf vs. Seed.

Edelman M, Colt M.

Front Chem. 2016 Jul 21;4:32. doi: 10.3389/fchem.2016.00032. eCollection 2016.

47.

Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.

Xie M, Lapidus RG, Sadowska M, Edelman MJ, Hosmane RS.

Bioorg Med Chem. 2016 Jun 15;24(12):2595-602. doi: 10.1016/j.bmc.2016.03.015. Epub 2016 Mar 9.

PMID:
27134120
48.

Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins.

Szafranski P, Gambin T, Dharmadhikari AV, Akdemir KC, Jhangiani SN, Schuette J, Godiwala N, Yatsenko SA, Sebastian J, Madan-Khetarpal S, Surti U, Abellar RG, Bateman DA, Wilson AL, Markham MH, Slamon J, Santos-Simarro F, Palomares M, Nevado J, Lapunzina P, Chung BH, Wong WL, Chu YWY, Mok GTK, Kerem E, Reiter J, Ambalavanan N, Anderson SA, Kelly DR, Shieh J, Rosenthal TC, Scheible K, Steiner L, Iqbal MA, McKinnon ML, Hamilton SJ, Schlade-Bartusiak K, English D, Hendson G, Roeder ER, DeNapoli TS, Littlejohn RO, Wolff DJ, Wagner CL, Yeung A, Francis D, Fiorino EK, Edelman M, Fox J, Hayes DA, Janssens S, De Baere E, Menten B, Loccufier A, Vanwalleghem L, Moerman P, Sznajer Y, Lay AS, Kussmann JL, Chawla J, Payton DJ, Phillips GE, Brosens E, Tibboel D, de Klein A, Maystadt I, Fisher R, Sebire N, Male A, Chopra M, Pinner J, Malcolm G, Peters G, Arbuckle S, Lees M, Mead Z, Quarrell O, Sayers R, Owens M, Shaw-Smith C, Lioy J, McKay E, de Leeuw N, Feenstra I, Spruijt L, Elmslie F, Thiruchelvam T, Bacino CA, Langston C, Lupski JR, Sen P, Popek E, Stankiewicz P.

Hum Genet. 2016 May;135(5):569-586. doi: 10.1007/s00439-016-1655-9. Epub 2016 Apr 12.

49.

Ending Childhood Poverty in America.

Edelman MW.

Acad Pediatr. 2016 Apr;16(3 Suppl):S6-7. doi: 10.1016/j.acap.2016.02.006. No abstract available.

PMID:
27044703
50.

Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.

Siegele BJ, Shilo K, Chao BH, Carbone DP, Zhao W, Ioffe O, Franklin WA, Edelman MJ, Aisner DL.

Lung Cancer. 2016 May;95:65-72. doi: 10.1016/j.lungcan.2016.02.012. Epub 2016 Feb 26. Review.

Supplemental Content

Loading ...
Support Center